Dengue

Common Name(s)

Dengue, Dengue virus, susceptibility to

Dengue is a virus that is carried by mosquitos and affects over 100 million people worldwide each year. The virus is passed to humans through mosquito bites. Those who inhabit or visit tropical or sub-tropical regions, particularly in urban or suburban areas, are most at risk for infection. Symptoms of Dengue include a high fever, intense headache or aching behind the eyes, joint pain, easy bruising, gum or nose bleeds, bone and muscle pain, swollen glands, and a rash. Symptoms usually appear 4-10 days after infection and last for 2-7 days.

There are four types of dengue virus: DEN-1, DEN-2, DEN-3, and DEN-4. Once an individual has recovered from one of these types, that individual will not develop symptoms from that same type again. When an individual is infected by a different type, however, there is a risk for severe dengue. Symptoms of severe dengue include vomiting (sometimes bloody), tiredness, severe stomach pain, fast breathing, restlessness, and bleeding gums. These symptoms occur after the high fever of dengue has dropped. Severe dengue requires immediate treatment, as it can cause the liquid part of the blood (plasma) to leak from small blood vessels (capillaries). This condition leads to severe loss of blood volume (shock) and can be life-threatening. Other complications may include internal bleeding, difficulty breathing, and accumulation of fluid in the body.

Severe dengue is treated by fluid replacement therapy. Dengue prevention methods focus on avoiding mosquitos, such as by getting rid of stagnant water in containers where mosquitos lay eggs and using bed nets during the night and mosquito repellant when outdoors. If you have been diagnosed with dengue, talk to your doctor about current treatment options. In addition, consult a medical professional for advice before traveling to areas where there is a potential to be infected by the dengue virus.

Source: Advocacy organizations associated with the condition.

 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Dengue" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Dengue" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Dengue" returned 3403 free, full-text research articles on human participants. First 3 results:

Serum Metabolomics Reveals Serotonin as a Predictor of Severe Dengue in the Early Phase of Dengue Fever.
 

Author(s): Liang Cui, Yie Hou Lee, Tun Linn Thein, Jinling Fang, Junxiong Pang, Eng Eong Ooi, Yee Sin Leo, Choon Nam Ong, Steven R Tannenbaum

Journal:

 

Effective triage of dengue patients early in the disease course for in- or out-patient management would be useful for optimal healthcare resource utilization while minimizing poor clinical outcome due to delayed intervention. Yet, early prognosis of severe dengue is hampered by the ...

Last Updated: 8 Apr 2016

Go To URL
Prediction of Dengue Outbreaks Based on Disease Surveillance and Meteorological Data.
 

Author(s): Aditya Lia Ramadona, Lutfan Lazuardi, Yien Ling Hii, Åsa Holmner, Hari Kusnanto, Joacim Rocklöv

Journal:

 

Research is needed to create early warnings of dengue outbreaks to inform stakeholders and control the disease. This analysis composes of a comparative set of prediction models including only meteorological variables; only lag variables of disease surveillance; as well as combinations ...

Last Updated: 1 Apr 2016

Go To URL
[Dengue vaccines. A reality for Argentina?].
 

Author(s): Pablo W Orellano, Oscar D Salomón

Journal: Medicina (B Aires). 2016 ;76(2):98-102.

 

Dengue outbreaks have occurred yearly in Argentina since 1998. A number of candidate vaccines have been tested in endemic countries. The most advanced one was licensed in three countries of Latin America for children over 9 years of age. In the present article the benefits and drawbacks ...

Last Updated: 4 May 2016

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Dengue" returned 234 free, full-text review articles on human participants. First 3 results:

Relevance of Non-communicable Comorbidities for the Development of the Severe Forms of Dengue: A Systematic Literature Review.
 

Author(s): Joao Toledo, Leyanna George, Eric Martinez, Adhara Lazaro, Wai Wai Han, Giovanini E Coelho, Silvia Runge Ranzinger, Olaf Horstick

Journal:

 

Patients with dengue fever and comorbidities seem to be at higher risk of developing complications and/or severe dengue compared to healthier individuals. This study systematically reviews the evidence related to comorbidities and dengue. A systematic literature review was performed ...

Last Updated: 5 Jan 2016

Go To URL
Tackling dengue fever: Current status and challenges.
 

Author(s): Taoufik Nedjadi, Sherif El-Kafrawy, Sayed S Sohrab, Philippe Desprès, Ghazi Damanhouri, Esam Azhar

Journal:

 

According to recent statistics, 96 million apparent dengue infections were estimated worldwide in 2010. This figure is by far greater than the WHO prediction which indicates the rapid spread of this disease posing a growing threat to the economy and a major challenge to clinicians ...

Last Updated: 9 Dec 2015

Go To URL
Guillain-Barre syndrome following dengue fever and literature review.
 

Author(s): Dissanayake Mudiyanselage Priyantha Udaya Kumara Ralapanawa, Senanayake Abeysinghe Mudiyanselage Kularatne, Widana Arachilage Thilak Ananda Jayalath

Journal:

 

Dengue is an arboviral infection that classically presents with fever, joint pain, headaches, skin flush and morbilliform rashes. The incidence of neurological symptoms and complications in dengue varies from 1 to 25% that include encephalopathy, Guillain-Barre syndrome (GBS), acute ...

Last Updated: 28 Nov 2015

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive Adults
 

Status: Not yet recruiting

Condition Summary: Dengue Fever; Dengue Hemorrhagic Fever; Human Immunodeficiency Virus

 

Last Updated: 12 Apr 2016

Go to URL
Study of a Booster Dose of a Tetravalent Dengue Vaccine in Subjects Who Previously Completed the 3-dose Schedule
 

Status: Recruiting

Condition Summary: Dengue Fever; Dengue Hemorrhagic Fever

 

Last Updated: 15 Apr 2016

Go to URL
Immunogenicity and Safety of 3-Dose and Booster Dose of Tetravalent Dengue Vaccine in Healthy Subjects 9 to 50 Years of Age
 

Status: Recruiting

Condition Summary: Dengue Fever; Dengue Hemorrhagic Fever

 

Last Updated: 3 May 2016

Go to URL